Oats in the treatment of childhood coeliac disease: a 2‐year controlled trial and a long‐term clinical follow‐up study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Summary: Background: The exclusion of oats from the diet in coeliac disease is controversial. Aim: To study the long‐term safety of oats in the treatment of children with coeliac disease. Methods: Altogether 32 children with coeliac disease were enrolled in a 2‐year controlled trial. Twenty‐three children in remission were randomized either to oats or gluten challenge; when small bowel histological relapse was evident after gluten challenge, a gluten‐free diet including oats was started. Furthermore, nine newly detected coeliac patients adopted an oat‐containing gluten‐free diet. Small bowel mucosal morphology, CD3+, αβ+ and γδ+ intraepithelial lymphocytes, human leucocyte antigen (HLA) DR expression and coeliac serology were determined. After the trial, the children were allowed to eat oats freely; follow‐up was extended up to 7 years. Results: In coeliac children in remission, oats had no detrimental effect on intestinal histology or serology during the 2‐year trial. In contrast, the gluten‐challenge group relapsed after 3–12 months. Complete recovery from the disease was accomplished in all relapsed and newly detected patients on an oat‐containing gluten‐free diet. After the trial, 86% of the children preferred to consume oats and they all remained in remission. Conclusion: In most children with coeliac disease, long‐term consumption of oats is well tolerated, and it does not result in small bowel mucosal deterioration or immune activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kutlu, T., Brousse, N., Rambaud, C., Le Deist, F., Schmitz, J., & Cerf-Bensussan, N. (1993) · Gut · doi:10.1136/gut.34.2.208 · Cited by 178
Cited by
Butt, M. S., Tahir-Nadeem, M., Khan, M. K. I., Shabir, R., & Butt, M. S. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-0698-7 · Cited by 559
“After the trial, 86% of the children preferred to consume oats and all of them remained in remission [ 47 ].”
BackgroundNutritional advantages of oats and opportunities for its processing as value added foods - a review
Rasane, P., Jha, A., Sabikhi, L., Kumar, A., & Unnikrishnan, V. S. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-013-1072-1 · Cited by 488
Advances in Celiac Disease and Gluten-Free Diet
Niewinski, M. M. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.01.011 · Cited by 280
Avena sativa(Oat), A Potential Neutraceutical and Therapeutic Agent: An Overview
Singh, R., De, S., & Belkheir, A. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.526725 · Cited by 267
Scientific Opinion on the evaluation of allergenic foods and food ingredients for labelling purposes
EFSA Panel on Dietetic Products, N. A. A. (. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3894 · Cited by 239
Metadata
- Authors
- HOLM, K., MÄKI, M., VUOLTEENAHO, N., MUSTALAHTI, K., ASHORN, M., RUUSKA, T., & KAUKINEN, K.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2006-04-28
- Volume
- 23
- Issue
- 10
- Pages
- 1463-1472
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2015753971
- Cited by
- 88
- References
- 1
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oats in the treatment of childhood coeliac disease: a 2‐year controlled trial and a long‐term clinical follow‐up study. https://app.cochat.ai/papers/10.1111/j.1365-2036.2006.02908.x
- The paper
- HOLM, K., MÄKI, M., VUOLTEENAHO, N., MUSTALAHTI, K., ASHORN, M., RUUSKA, T., & KAUKINEN, K. (2006). Oats in the treatment of childhood coeliac disease: a 2‐year controlled trial and a long‐term clinical follow‐up study. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2006.02908.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.